Ink4a/Arf−/−PTEN+/− mice experienced a much faster rate of PIN development compared to Ink4a/Arf+/+PTEN+/− controls; however, these mice did not develop adenocarcinomas [50]. Here, CDKN2A is linked to adenocarcinoma.